Menu Search
Equities

Astellas Pharma Inc

ALPMY:PNK

Astellas Pharma Inc

Actions
  • Price (USD)12.15
  • Today's Change-0.04 / -0.33%
  • Shares traded50.11k
  • 1 Year change-18.24%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 20:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		4503:TYO since
announced		Transaction
value
Propella Therapeutics IncDeal completed15 Nov 202315 Nov 2023Deal completed-1.34%175.00m
Data delayed at least 20 minutes, as of Sep 19 2024 07:00 BST.

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
Hantz Financial Services, Inc.as of 30 Jun 2024157.91k0.01%
LifeSci Fund Management LLCas of 30 Jun 202485.00k0.01%
RhumbLine Advisers LPas of 30 Jun 202433.59k0.00%
Aperio Group LLCas of 31 Jul 202421.25k0.00%
Johnson Investment Counsel, Inc.as of 31 Jul 202410.30k0.00%
ShariaPortfolio, Inc.as of 05 Sep 20243.59k0.00%
GAMMA Investing LLCas of 30 Jun 20243.31k0.00%
PNC Investments LLCas of 30 Jun 202440.000.00%
First Horizon Advisors, Inc.as of 30 Jun 20240.000.00%
Arrowstreet Capital LPas of 31 Dec 20230.000.00%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.